Physician profile
Casey J Holmes
NPI 1720387061
$11,701.40
in general payments reported to CMS, 2019-2025
14 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what 77% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $349 · 2021: $418 · 2022: $763 · 2023: $395 · 2024: $7,863 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,577 · Food and Beverage: $1,198 · Consulting Fee: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,576.72 |
| Food and Beverage | $1,198.27 |
| Consulting Fee | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $7,744.37 | 2022-2024 | Integra |
| Allergan, INC. | $1,182.87 | 2019-2022 | |
| Abbvie INC. | $1,138.87 | 2023-2025 | |
| Tela Bio, INC. | $760.75 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Endo Pharmaceuticals INC. | $216.23 | 2019 | |
| Axogen | $209.65 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $103.59 | 2020 | |
| Coopersurgical, INC. | $96.01 | 2019 | |
| Eagle Pharmaceuticals, INC. | $79.66 | 2019 | |
| Mentor Worldwide LLC | $63.56 | 2022 | |
| Galderma Laboratories, L.P. | $31.59 | 2021-2022 | |
| Sientra, INC. | $29.06 | 2022 | |
| Kci USA, INC. | $22.73 | 2022 | |
| Hologic Sales and Service, LLC | $22.46 | 2024 | Acessa Provu System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.